Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2018 | 2 |
2020 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Metformin Derivative HL156A Reverses Multidrug Resistance by Inhibiting HOXC6/ERK1/2 Signaling in Multidrug-Resistant Human Cancer Cells.
Pharmaceuticals (Basel). 2020 Aug 28;13(9):218. doi: 10.3390/ph13090218.
Pharmaceuticals (Basel). 2020.
PMID: 32872293
Free PMC article.
Antioxidant modifications induced by the new metformin derivative HL156A regulate metabolic reprogramming in SAMP1/kl (-/-) mice.
Kim SA, Lam TG, Yook JI, Ahn SG.
Kim SA, et al. Among authors: lam tg.
Aging (Albany NY). 2018 Sep 16;10(9):2338-2355. doi: 10.18632/aging.101549.
Aging (Albany NY). 2018.
PMID: 30222592
Free PMC article.
Item in Clipboard
New metformin derivative HL156A prevents oral cancer progression by inhibiting the insulin-like growth factor/AKT/mammalian target of rapamycin pathways.
Lam TG, Jeong YS, Kim SA, Ahn SG.
Lam TG, et al.
Cancer Sci. 2018 Mar;109(3):699-709. doi: 10.1111/cas.13482. Epub 2018 Jan 27.
Cancer Sci. 2018.
PMID: 29285837
Free PMC article.
Item in Clipboard
Cite
Cite